Life Insurance With Psoriasis in Canada: Rates and Real Odds

There is a common assumption that an autoimmune diagnosis like psoriasis automatically means higher premiums or a decline. For most people it does not. Canadian underwriters are far less interested in the label than in one question: is it under control, and is anything else going on.

Short answer: yes, you can get life insurance with psoriasis, and often at standard rates when it is well controlled.

Well-controlled psoriasis on its own rarely changes what a Canadian insurer offers. Rates tend to move only when the disease is severe, when it is treated with systemic or biologic medication, or when it comes with another condition such as psoriatic arthritis, heart, or metabolic risk. This guide covers where the line sits and how the application is actually handled.

What this guide covers:

• How Psoriasis Affects a Life Insurance Application
• When Psoriasis Starts to Affect Your Rates
• Psoriatic Arthritis and Life Insurance
• How Changing Psoriasis Medication Affects Your Application
• What Underwriters Ask For (and Why)
• How to Get the Best Rates With Psoriasis
• Your Coverage Options: Term, Permanent, and No-Medical
• Frequently Asked Questions

How Psoriasis Affects a Life Insurance Application

From my experience, psoriasis has very little impact on underwriting. In and of itself, it is usually not a concern.

That surprises people. They hear the word “autoimmune” and assume they are automatically looking at higher premiums or a decline. But a Canadian underwriter is not reacting to the diagnosis. They are looking at whether it is controlled and whether anything else is going on in your overall health history. Psoriasis on its own, well managed, usually reads standard.

Here is the honest version, 25 years in: In my experience, I have not had a client rated or declined for psoriasis alone, and any offer still comes down to the full file. When a psoriasis file did get complicated, it was never the skin doing it. It was something else on the application.

So the real work is not defending the psoriasis. It is reading the whole picture and knowing which insurer sees that picture the way you would want them to. When I am not certain where a file lands, I do a preliminary assessment first: an email to an underwriter with the medical details and no name attached, so I get a rough answer before anything official is ever submitted. Any offer still depends on the full application, but that step means very few of my clients are ever caught off guard.

When Psoriasis Starts to Affect Your Rates

Psoriasis starts to affect your rates when it stops being just a skin condition. Severe or systemic disease can move an offer, and so can a second condition riding alongside it.

On its own, psoriasis along with nothing else is typically a non-concern. But paired with another comorbidity, depending on what it is, it can become a challenge. That is the part people get backwards. They fixate on how bad their skin looks during a flare. Underwriters care more about what the treatment says about severity, and what else is on the file.

So the three things that move the needle are how it is treated, how stable it has been, and what comes with it. A long stretch of good control looks nothing like frequent flares and recent medication changes. And cardiovascular and metabolic risk is the part that carries real weight, not the skin.

To put a rough shape on it, Sun Life’s own underwriting guidance treats a well-managed case as standard, with ratings rising toward the moderate range only as severity and medication escalate. Other carriers land differently, which is the whole reason comparing them matters. These are preliminary indications, not quotes, and every one depends on the full application.

Psoriatic Arthritis and Life Insurance

Psoriatic arthritis is the point where a psoriasis file usually stops being a non-event. It is the autoimmune progression, not the skin, that makes an underwriter slow down.

About one in five people with psoriasis develop it. Once the joints are involved, the insurer is no longer looking at a skin condition. They are looking at an inflammatory disease that can carry more systemic risk, and they price for that.

The reframe I give people: a rating here is a real, workable offer for the current risk, not a rejection. And it is not permanent. If the disease stays stable, that risk classification can be revisited later.

How Changing Psoriasis Medication Affects Your Application

Changing psoriasis medication can affect your application, but not in the way people fear. A recent switch is not a red flag on its own. What underwriters want is a stretch of stability on whatever you are taking now.

Here is the thing I tell people. The moment right after you step up to a new medication is the worst moment to apply. Not because the drug looks bad, but because the file has no track record yet. Give it time, and the same drug that looked like an escalation now reads as a plan that is working.

Which direction you are moving matters too. Coming down off a biologic because your skin cleared is a good story, and it should be told that way on the application. Escalating because nothing else worked is a different story, and it is usually worth waiting out the stability window before applying. Either way, the medication itself is rarely the deciding factor. The pattern around it is. You can read more on how medications affect a life insurance application across conditions.

What Underwriters Ask For (and Why)

Underwriters ask for three things on a psoriasis file: how long you have had it, how it is treated, and whether anything else is going on. Everything on the application ladders back to those three questions.

You do not need to chase down a thick medical package before you talk to a broker. Most of this your dermatologist or family doctor already has on file, and for anything formal, the insurer requests it directly through an Attending Physician Statement, a report pulled straight from your doctor. Your job is mostly to be accurate and complete.

One rule sits above all of this: disclose everything, plainly. Leaving something off to look like a cleaner risk is the fastest way to hand the insurer a reason to contest a claim later. A rated policy that pays out beats a cheap one that does not. Full disclosure is not just the honest move, it is the one that protects the people you are buying the coverage for.

How to Get the Best Rates With Psoriasis

The best rates with psoriasis come from timing and matching, not from hiding anything. Apply when your condition is stable, and apply to the insurer that reads your file the way you would want.

Same person, same skin, different insurer, different answer. That is the whole game with any managed condition. One carrier shrugs at a controlled case, another asks for more. Knowing which is which before you submit is most of the value a broker brings.

Your Coverage Options: Term, Permanent, and No-Medical

With well-controlled psoriasis, most of the normal coverage options are open to you, at normal rates. The condition rarely narrows the menu on its own. It is only the more complex files that lean toward the no-medical routes.

Here is how I think about the choices, from the most common starting point to the fallback:

For almost everyone with psoriasis, the honest answer is that you belong at the top of that list, not the bottom. Simplified issue and guaranteed issue exist for the harder files, and I treat them as fallbacks, not the opening move. We start by trying for fully underwritten coverage, because that is where the pricing is best.

Frequently Asked Questions